Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
This page covers the main factors that move indices, including earnings, policy, and macro conditions, with tips for interpreting changes.
28,658 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A growing chorus of analysts says the AI boom could lift nvidia stock will trade into the higher end of its range by ...
Tuesday brought a modest pullback for Salesforce as tech stocks wobbled. This article explains the drivers behind the...
Tesla shares slipped as three major developments tug the stock in mixed directions: stricter autonomous driving overs...
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...
As custom AI chips gain traction, investors wonder if amazon alphabet's custom chips can rival Nvidia. This article b...
A new proposal aims to end blind signing in Ethereum wallets. The change could reduce scam losses and tighten securit...
As AI systems evolve, a watchdog warns 'rogue deployment' risk at top labs. This deep dive explains what rogue deploy...
Crypto fund flows are shifting. While bitcoin, ethereum etfs shed money, hyperliquid funds are drawing fresh buyers i...
Solana has faced headwinds, but many investors wonder if solana about have biggest could finally arrive in the second...
Thailand's central bank has flagged unusual stablecoin transfers as part of a broader crackdown on the grey economy. ...